sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
aquaflor 500 mg premix
intervet international -
egocin 155 premix
krka -
enroxil predmešanica
krka -
geotrim p - np
lincomix 44 - np - prenos
floron 2g-10g predmesanica
krka -
bendamustin mylan 2,5 mg/ml prašek za koncentrat za raztopino za infundiranje
mylan s.a.s. - bendamustinijev klorid - prašek za koncentrat za raztopino za infundiranje - bendamustinijev klorid 2,5 mg / 1 ml - bendamustin
bendamustin mylan 2,5 mg/ml prašek za koncentrat za raztopino za infundiranje
mylan s.a.s. - bendamustinijev klorid - prašek za koncentrat za raztopino za infundiranje - bendamustinijev klorid 2,5 mg / 1 ml - bendamustin
anamex
norbrook laboratories limited station works newry co down -